참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | L-Glutamic Acid | HCID 33032 | — |
| 반응물 | 1,1'-Carbonyldiimidazole | HCID 68263 | — |
| 생성물 | Glu urea imidazole | HCID 131729281 | — |
반응 단계
Compounds 217-220, 230 and 231a, b, and c were all prepared in overall yields ranging from 20-40% following the route depicted in Scheme 7. The first step, performed at 0° C. under inert conditions used the di-t-butyl ester of Glutamic acid with CDI in the presence of base to form the intermediate Glu-urea-imidazole derivative 2. This intermediate was activated with MeOTf under basic conditions to afford the methylated imidazole 3, which under inert conditions reacted readily with amines. The tert-butyl ester protecting groups were removed using 20% TFA in DCM for 1 to 4 hour at room temperature. Upon completion of the deprotection, the reactions were concentrated on a rotary evaporator or blown dry with nitrogen and purified on a silica column or recrystallized. The final products were tested in vitro and in vivo.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08840865B2 |
|---|
| 출처 데이터셋 | uspto-grants-2014_09 |
|---|
| ORD ID | ord-8605a7ee51dc4bbb86a11d9391d936d1 |
|---|
| 출처 메모 | uspto-grants-2014_09 |
|---|